112 related articles for article (PubMed ID: 12969773)
21. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
22. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
[TBL] [Abstract][Full Text] [Related]
23. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
[TBL] [Abstract][Full Text] [Related]
25. 15-deoxy-delta 12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis.
Watanabe K; Yokoyama Y; Kokuryo T; Kawai K; Kitagawa T; Seki T; Nakagawa A; Nagino M
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G410-8. PubMed ID: 20056897
[TBL] [Abstract][Full Text] [Related]
26. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
Aoun P; Simpkins JW; Agarwal N
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
[TBL] [Abstract][Full Text] [Related]
27. 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?
Powell WS
J Clin Invest; 2003 Sep; 112(6):828-30. PubMed ID: 12975467
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
30. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis.
Rohn TT; Wong SM; Cotman CW; Cribbs DH
Neuroreport; 2001 Mar; 12(4):839-43. PubMed ID: 11277593
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue.
Ma H; Sprecher HW; Kolattukudy PE
J Biol Chem; 1998 Nov; 273(46):30131-8. PubMed ID: 9804768
[TBL] [Abstract][Full Text] [Related]
32. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
Genovese T; Cuzzocrea S; Di Paola R; Mazzon E; Mastruzzo C; Catalano P; Sortino M; Crimi N; Caputi AP; Thiemermann C; Vancheri C
Eur Respir J; 2005 Feb; 25(2):225-34. PubMed ID: 15684285
[TBL] [Abstract][Full Text] [Related]
33. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
[TBL] [Abstract][Full Text] [Related]
34. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
36. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
[TBL] [Abstract][Full Text] [Related]
37. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.
Petrova TV; Akama KT; Van Eldik LJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4668-73. PubMed ID: 10200320
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway.
Napimoga MH; Vieira SM; Dal-Secco D; Freitas A; Souto FO; Mestriner FL; Alves-Filho JC; Grespan R; Kawai T; Ferreira SH; Cunha FQ
J Immunol; 2008 Jan; 180(1):609-17. PubMed ID: 18097063
[TBL] [Abstract][Full Text] [Related]
39. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway.
González E; Jawerbaum A; Sinner D; Pustovrh C; White V; Capobianco E; Xaus C; Peralta C; Roselló-Catafau J
Nitric Oxide; 2002 Mar; 6(2):214-20. PubMed ID: 11890746
[TBL] [Abstract][Full Text] [Related]
40. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
